Gene · 2823
Papers1,924
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 1,924
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of molecular subtypes and a prognostic signature based on m6A/m5C/m1A-related genes in lung adenocarcinoma. | Sci Rep | 2024 | 38555384 | PubTator, text mining | PubMed |
| Internal m 6 A and m 7 G RNA modifications in hematopoietic system and acute myeloid leukemia. | Chin Med J (Engl) | 2024 | 38545694 | PubTator, text mining | PubMed |
| M6A-mediated molecular patterns and tumor microenvironment infiltration characterization in nasopharyngeal carcinoma. | Cancer Biol Ther | 2024 | 38532632 | PubTator, text mining | PubMed |
| N6-methyladenosine reader hnRNPA2B1 recognizes and stabilizes NEAT1 to confer chemoresistance in gastric cancer. | Cancer Commun (Lond) | 2024 | 38512764 | PubTator, text mining | PubMed |
| The antagonistic effect of FTO on METTL14 promotes AKT3 m6A demethylation and the progression of esophageal cancer. | J Cancer Res Clin Oncol | 2024 | 38491196 | PubTator, text mining | PubMed |
| Regulation of N6-methyladenosine modification in erythropoiesis and thalassemia. | Clin Genet | 2024 | 38488342 | PubTator, text mining | PubMed |
| ALKBH5-mediated upregulation of CPT1A promotes macrophage fatty acid metabolism and M2 macrophage polarization, facilitating malignant progression of colorectal cancer. | Exp Cell Res | 2024 | 38479704 | PubTator, text mining | PubMed |
| Correlations of m6A Methylation-Related lncRNAs with the Prognosis of Papillary Thyroid Carcinoma. | Int J Gen Med | 2024 | 38476625 | PubTator, text mining | PubMed |
| RNA N6-Methyladenosine Modification in DNA Damage Response and Cancer Radiotherapy. | Int J Mol Sci | 2024 | 38473842 | PubTator, text mining | PubMed |
| Phosphorylated SHMT2 Regulates Oncogenesis Through m6A Modification in Lung Adenocarcinoma. | Adv Sci (Weinh) | 2024 | 38460155 | PubTator, text mining | PubMed |
| Atomic Mutagenesis of N6-Methyladenosine Reveals Distinct Recognition Modes by Human m6A Reader and Eraser Proteins. | J Am Chem Soc | 2024 | 38445613 | PubTator, text mining | PubMed |
| N6-methyladenosine demethyltransferase FTO mediated m6A modification of estrogen receptor alpha in non-small cell lung cancer tumorigenesis. | Oncogene | 2024 | 38443681 | PubTator, text mining | PubMed |
| Low- and High-Grade Glioma-Associated Vascular Cells Differentially Regulate Tumor Growth. | Mol Cancer Res | 2024 | 38441553 | PubTator, text mining | PubMed |
| FoxO1 promotes ovarian cancer by increasing transcription and METTL14-mediated m6A modification of SMC4. | Cancer Sci | 2024 | 38403332 | PubTator, text mining | PubMed |
| Characterization of the m6A/m1A/m5C/m7G-related regulators on the prognosis and immune microenvironment of glioma by integrated analysis of scRNA-seq and bulk RNA-seq data. | J Gene Med | 2024 | 38391150 | PubTator, text mining | PubMed |
| The FTO Mediated N6-Methyladenosine Modification of DDIT4 Regulation with Tumorigenesis and Metastasis in Prostate Cancer. | Research (Wash D C) | 2024 | 38384328 | PubTator, text mining | PubMed |
| METTL14 affects UVB-induced human dermal fibroblasts photoaging via miR-100-3p biogenesis in an m6A-dependent manner. | Aging Cell | 2024 | 38380598 | PubTator, text mining | PubMed |
| LRPPRC promotes glycolysis by stabilising LDHA mRNA and its knockdown plus glutamine inhibitor induces synthetic lethality via m6 A modification in triple-negative breast cancer. | Clin Transl Med | 2024 | 38372449 | PubTator, text mining | PubMed |
| Comprehensive analysis of m6 A methylome and transcriptome by Nanopore sequencing in clear cell renal carcinoma. | Mol Carcinog | 2024 | 38362848 | PubTator, text mining | PubMed |
| miR615-3p inhibited FBLN1 and osteogenic differentiation of umbilical cord mesenchymal stem cells by associated with YTHDF2 in a m6A-miRNA interaction manner. | Cell Prolif | 2024 | 38353178 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2823/papers?page=14